NeoGenomics, Inc. (NEO)

NeoGenomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	145.54	159.62	367.01	342.49	263.18	316.83
Short-Term Investments	-	-	19.83	72.72	174.81	198.56
Cash & Short-Term Investments	145.54	159.62	386.84	415.2	437.99	515.39
Cash Growth	-11.09%	-58.74%	-6.83%	-5.20%	-15.02%	73.97%
Accounts Receivable	175.41	159.24	150.54	131.23	119.71	112.13
Inventory	27.14	28.57	26.75	24.16	24.28	23.4
Other Current Assets	33.4	28.86	31.89	26.23	23.31	30.59
Total Current Assets	381.48	376.29	596.02	596.81	605.29	681.51
Net Property, Plant & Equipment	166.2	163.28	173.69	183.78	198.61	211.66
Other Intangible Assets	271.26	286.53	339.68	373.13	408.26	442.33
Goodwill	524	524.34	522.77	522.77	522.77	527.12
Other Long-Term Assets	9.31	9.39	5.89	4.74	5.11	7.17
Total Assets	1,352	1,360	1,638	1,681	1,740	1,870

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	20.95	23.09	21.61	20.33	20.51	17.92
Accrued Expenses	79.31	59.58	75.07	68.23	55.21	56.1
Current Portion of Long-Term Debt	-	-	200.78	-	-	-
Current Portion of Leases	5.43	4.78	3.38	5.61	6.65	8.02
Unearned Revenue	0.19	0.85	0.41	2.13	7.56	5.19
Total Current Liabilities	105.88	88.3	301.24	96.3	89.93	87.23
Long-Term Debt	374.24	341.86	340.34	538.2	535.32	532.48
Long-Term Leases	68.7	62.82	60.84	67.87	68.95	72.29
Other Long-Term Liabilities	17.69	30.29	33.28	37.32	47.81	69.5
Total Long-Term Liabilities	460.63	434.97	434.46	643.39	652.08	674.27
Total Liabilities	566.51	523.27	735.7	739.69	742.01	761.5

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.13	0.13	0.13	0.13	0	0.12
Treasury Stock	-25	-	-	-	-	-
Additional Paid-in Capital	1,259	1,270	1,228	1,190	1,161	1,124
Accumulated Other Comprehensive Income	0	0	-0.21	-1.67	-3.9	-0.64
Retained Earnings	-448.67	-433.81	-325.78	-247.06	-159.09	-14.84
Total Common Shareholders' Equity	785.73	836.56	902.34	941.54	997.9	1,108
Shareholders' Equity	785.73	836.56	902.34	941.54	998.02	1,108
Total Liabilities & Equity	1,352	1,360	1,638	1,681	1,740	1,870

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	448.37	409.46	605.33	611.68	610.93	612.79
Net Cash (Debt)	-302.83	-249.84	-218.49	-196.48	-172.94	-97.4
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-2.34	-1.95	-1.73	-1.57	-1.39	-0.81
Book Value	785.73	836.56	902.34	941.54	997.9	1,108
Book Value Per Share	6.08	6.53	7.12	7.50	8.03	9.24
Tangible Book Value	-9.53	25.69	39.89	45.64	66.87	138.84
Tangible Book Value Per Share	-0.07	0.20	0.31	0.36	0.54	1.16

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Jul 28, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 3, 2026

Data Sources Report a data error